CIP
GMED icon

Champlain Investment Partners’s Globus Medical GMED Stock Holding History

Champlain Investment Partners’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.2M Sell
350,053
-364,920
-51% -$32.8M 0.38% 91
2025
Q4 		$62.4M Sell
714,973
-731,641
-51% -$55.5M 0.63% 67
2025
Q3 		$82.8M Buy
1,446,614
+365,418
+34% +$21M 0.62% 67
2025
Q2 		$63.8M Buy
1,081,196
+39,988
+4% +$2.58M 0.45% 94
2025
Q1 		$76.2M Sell
1,041,208
-57,564
-5% -$4.76M 0.55% 80
2024
Q4 		$90.9M Sell
1,098,772
-695,865
-39% -$54.9M 0.58% 70
2024
Q3 		$128M Sell
1,794,637
-671,821
-27% -$47.4M 0.78% 55
2024
Q2 		$169M Sell
2,466,458
-37,925
-2% -$2.27M 1.04% 34
2024
Q1 		$134M Buy
2,504,383
+503,745
+25% +$27.1M 0.77% 50
2023
Q4 		$107M Buy
2,000,638
+83,262
+4% +$4.06M 0.63% 64
2023
Q3 		$95.2M Buy
1,917,376
+214,626
+13% +$12M 0.62% 65
2023
Q2 		$101M Buy
1,702,750
+57,435
+3% +$3.27M 0.62% 68
2023
Q1 		$93.2M Sell
1,645,315
-336,030
-17% -$21.5M 0.59% 77
2022
Q4 		$147M Sell
1,981,345
-61,635
-3% -$4.2M 0.94% 40
2022
Q3 		$122M Buy
2,042,980
+310,115
+18% +$18.7M 0.83% 51
2022
Q2 		$97.3M Buy
1,732,865
+55,550
+3% +$3.65M 0.63% 68
2022
Q1 		$124M Sell
1,677,315
-80,420
-5% -$5.59M 0.64% 71
2021
Q4 		$127M Buy
1,757,735
+123,500
+8% +$8.97M 0.57% 78
2021
Q3 		$125M Buy
1,634,235
+114,895
+8% +$9.23M 0.6% 73
2021
Q2 		$118M Sell
1,519,340
-1,385
-0.1% -$98.5K 0.56% 81
2021
Q1 		$93.8M Buy
1,520,725
+442,180
+41% +$28M 0.49% 90
2020
Q4 		$70.3M Buy
1,078,545
+35,995
+3% +$2.07M 0.4% 88
2020
Q3 		$51.6M Buy
1,042,550
+274,070
+36% +$14.1M 0.35% 95
2020
Q2 		$36.7M Buy
768,480
+122,130
+19% +$5.89M 0.26% 105
2020
Q1 		$27.5M Buy
+646,350
New +$31.9M 0.25% 109
2016
Q4 		– Sell
-1,260,615
Closed -$28.5M – 131
2016
Q3 		$28.5M Sell
1,260,615
-125,595
-9% -$2.95M 0.43% 97
2016
Q2 		$33M Sell
1,386,210
-16,335
-1% -$392K 0.57% 79
2016
Q1 		$33.3M Sell
1,402,545
-195,950
-12% -$4.79M 0.6% 75
2015
Q4 		$44.5M Sell
1,598,495
-192,791
-11% -$4.84M 0.76% 56
2015
Q3 		$37M Sell
1,791,286
-35,964
-2% -$911K 0.65% 66
2015
Q2 		$46.9M Sell
1,827,250
-469,770
-20% -$11.9M 0.74% 62
2015
Q1 		$58M Sell
2,297,020
-9,805
-0.4% -$239K 0.99% 37
2014
Q4 		$54.8M Sell
2,306,825
-67,355
-3% -$1.49M 0.87% 46
2014
Q3 		$46.7M Buy
2,374,180
+530,855
+29% +$10.9M 0.81% 51
2014
Q2 		$44.1M Buy
1,843,325
+255,980
+16% +$6.17M 0.72% 63
2014
Q1 		$42.2M Sell
1,587,345
-46,520
-3% -$1.11M 0.73% 62
2013
Q4 		$33M Buy
1,633,865
+630,795
+63% +$11.7M 0.58% 83
2013
Q3 		$17.5M Buy
+1,003,070
New +$17.4M 0.33% 108

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Champlain Investment Partners's GMED Position: Q1 2026 in Review

Champlain Investment Partners reduced its Globus Medical (GMED) stake by 51% in Q1 2026, selling an estimated $32.8M and leaving 350,053 shares worth $30.2M. The position accounts for 0.38% of the portfolio, ranked #91.

Champlain Investment Partners first reported a position in GMED in Q3 2013 and has held it in 38 quarters since. The position peaked at $169M in Q2 2024. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Champlain Investment Partners held 350,053 shares of Globus Medical worth $30.2M as of Q1 2026.
  • Champlain Investment Partners sold 364,920 Globus Medical shares in Q1 2026, an estimated $32.8M.
  • Globus Medical made up 0.38% of Champlain Investment Partners's portfolio in Q1 2026, its #91 holding.
  • Champlain Investment Partners first reported a position in Globus Medical in Q3 2013 and has held it in 38 quarters since.
  • Champlain Investment Partners's Globus Medical position peaked at $169M in Q2 2024.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Champlain Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.